Learn how GA4GH helps expand responsible genomic data use to benefit human health.
Learn how GA4GH helps expand responsible genomic data use to benefit human health.
Our Strategic Road Map defines strategies, standards, and policy frameworks to support responsible global use of genomic and related health data.
Discover how a meeting of 50 leaders in genomics and medicine led to an alliance uniting more than 5,000 individuals and organisations to benefit human health.
GA4GH Inc. is a not-for-profit organisation that supports the global GA4GH community.
To guide our collaborative, globe-spanning alliance, GA4GH relies on a Standards Steering Committee and an Executive Committee.
The Funders Forum brings together organisations that offer both financial support and strategic guidance.
The EDI Advisory Group responds to issues raised in the GA4GH community, finding equitable, inclusive ways to build products that benefit diverse groups.
Distributed across four Host Institutions, our staff team supports the mission and operations of GA4GH.
Curious who we are? Meet the people and organisations across six continents who make up GA4GH.
More than 500 organisations connected to genomics — in healthcare, research, patient advocacy, industry, and beyond — have signed onto the mission and vision of GA4GH as Organisational Members.
These core Organisational Members are genomic data initiatives that have committed resources to guide GA4GH work and pilot our products.
This subset of Organisational Members whose networks or infrastructure align with GA4GH priorities has made a long-term commitment to engaging with our community.
Local and national organisations assign experts to spend at least 30% of their time building GA4GH products.
Anyone working in genomics and related fields is invited to participate in our inclusive community by creating and using new products.
Wondering what GA4GH does? Learn how we find and overcome challenges to expanding responsible genomic data use for the benefit of human health.
Study Groups define needs. Participants survey the landscape of the genomics and health community and determine whether GA4GH can help.
Work Streams create products. Community members join together to develop technical standards, policy frameworks, and policy tools that overcome hurdles to international genomic data use.
GIF solves problems. Organisations in the forum pilot GA4GH products in real-world situations. Along the way, they troubleshoot products, suggest updates, and flag additional needs.
NIF finds challenges and opportunities in genomics at a global scale. National programmes meet to share best practices, avoid incompatabilities, and help translate genomics into benefits for human health.
Communities of Interest find challenges and opportunities in areas such as rare disease, cancer, and infectious disease. Participants pinpoint real-world problems that would benefit from broad data use.
See all our products — always free and open-source. Do you work on cloud genomics, data discovery, user access, data security or regulatory policy and ethics? Need to represent genomic, phenotypic, or clinical data? We’ve got a solution for you.
All GA4GH standards, frameworks, and tools follow the Product Development and Approval Process before being officially adopted.
Learn how other organisations have implemented GA4GH products to solve real-world problems.
Help us transform the future of genomic data use! See how GA4GH can benefit you — whether you’re using our products, writing our standards, subscribing to a newsletter, or more.
Help create new global standards and frameworks for responsible genomic data use.
Align your organisation with the GA4GH mission and vision.
Solve your real-world data problems with support from this valuable network of global institutions.
Work with like-minded groups committed to better data use in areas like rare disease, cancer, and infectious disease.
Share your thoughts on all GA4GH products currently open for public comment.
Solve real problems by aligning your organisation with the world’s genomics standards. We offer software dvelopers both customisable and out-of-the-box solutions to help you get started.
Learn more about upcoming GA4GH events. See reports and recordings from our past events.
Speak directly to the global genomics and health community while supporting GA4GH strategy.
Be the first to hear about the latest GA4GH products, upcoming meetings, new initiatives, and more.
Questions? We would love to hear from you.
Read news, stories, and insights from the forefront of genomic and clinical data use.
Attend an upcoming GA4GH event, or view meeting reports from past events.
See new projects, updates, and calls for support from the Work Streams.
Read academic papers coauthored by GA4GH contributors.
Listen to our podcast OmicsXchange, featuring discussions from leaders in the world of genomics, health, and data sharing.
Check out our videos, then subscribe to our YouTube channel for more content.
View the latest GA4GH updates, Genomics and Health News, Implementation Notes, GDPR Briefs, and more.
Discover all things GA4GH: explore our news, events, videos, podcasts, announcements, publications, and newsletters.
29 Sep 2020
The Steering Committee of the Global Alliance for Genomics and Health (GA4GH) has approved three new products that support the genomic and health data collection process. Together, these three deliverables—ERR Policy, MRCG, and CCGR—facilitate genomic and health research that protects the interests of both participants and researchers.
The Steering Committee of the Global Alliance for Genomics and Health (GA4GH) has approved three new products that support the genomic and health data collection process. The Ethics Review Recognition (ERR) Policy is a document detailing key elements of the ethics review process to improve how Research Ethics Committees review research projects involving genomic and related health data. The other two new deliverables—Machine Readable Consent Guidance (MRCG) and Consent Clauses for Genomic Research (CCGR)—both aim to facilitate interoperable data sharing that upholds data donor consent. Together, these three deliverables facilitate genomic and health research that protects the interests of both participants and researchers.
Ethics Review Recognition Policy
The ERR Policy, produced by the GA4GH Regulatory and Ethics Work Stream (REWS), was developed to standardize the process of reviewing research projects in which genomic or health data is to be shared across institutional or national boundaries. Currently, Research Ethics Committees—sometimes known as Ethics Review Boards—review proposed studies that involve human research participants to ensure the ways in which data is collected and used are ethical, legal, and respectful of each participant’s wellbeing. As many new studies work to utilize existing data, additional ethics reviews are necessary. “This exacerbates the burden placed on Research Ethics Committees to thoroughly and consistently review proposals, increases the time a proposed research study spends waiting for approval, and uses up financial resources that could otherwise be allocated to advances in research and medicine,” said Edward Dove, Co-Chair of the REWS.
The ERR Policy addresses the problems currently faced by Research Ethics Committees and researchers by establishing a standard framework for ethics reviews.
“When this standard process is recognized and accepted by Research Ethics Committees around the world,” explained Dove, “proposed studies will only need to undergo an ethics review once and the review will be accepted by ethics committees in different institutions and countries.”
Consent Clauses for Genomic Research
The CCGR is a document outlining sample consent language for aspects of genomic research—particularly around data sharing and data linkage—that researchers can use in creating consent forms. The CCGR is part of an ongoing effort from the REWS Consent Task Force which aims to provide sample consent language for a variety of research and healthcare settings in which a patient or participant’s genomic and health data may later be shared or used in future studies. Using the CCGR to draft consent documents, researchers can ensure that their participants understand how their data may be used and shared throughout its lifetime and provide their consent accordingly.
“In addition to increasing interoperability, the CCGR also helps researchers and review committees by eliminating ambiguity around the language that is appropriate to use in consent documents and streamlining the development of such documents,” said Susan Wallace, who led the development and maintains updates of the CCGR.
Machine Readable Consent Guidance
The MRCG was produced by the GA4GH Data Use and Researcher Identities (DURI) Work Stream in collaboration with REWS and outlines a process for mapping consent language to the standard data use terms outlined in the GA4GH Data Use Ontology (DUO). DUO terms describe the scope of permitted research purposes for which a dataset can be used in a machine readable manner. Currently, Data Access Committees (DACs) manually evaluate each data access request to determine if a researcher’s intended use aligns with the permissions the participant granted when consenting to donate their data in the primary research project. Using MRCG, the participant consent form can be created in a way that aligns unambiguously to DUO codes and thus can be electronically attached to that participant’s data in perpetuity. Together, the MRCG and CCGR lessen the workload of DACs and ensure consistency in approving data access requests by requiring human-readable consent forms to use standard language around data sharing and data linkage as a prerequisite for translating consent forms into a machine-readable format.
“The interoperability between MRCG and other GA4GH deliverables that streamline the process of granting access to datasets is critical,” said Tiffany Boughtwood, who helped develop the MRCG and DUO. “As these standards are adopted, we’re going to see data being used much more frequently and rapidly, which means more advancements in science and medicine.”
The ERR Policy, CCGR, and MRCG each support the ethical and responsible sharing of genomic and health data across boundaries by simplifying and standardizing the ethics review and consent processes. Institutional Review Boards or Ethics Review Committees wishing to adopt and implement these standards can contact the REWS Coordinators (ERR and CCGR) or DURI Work Stream Technical Manager, Melissa Konopko (MRCG).